Preparation method of bisoprolol fumarate

By combining bisoprolol with non-fumaric acid organic acid, recrystallization and purification of mixed solvents, and converting it into bisoprolol fumaric acid in dichloromethane-aqueous solution, the difficulty of improving purity in the prior art is solved and The problem of low yield has achieved efficient and stable preparation of high-purity bisoprolol fumarate, which is suitable for large-scale production.

CN118908845APending Publication Date: 2024-11-08SHANDONG KEXIN PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410959732.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the prior art, it is difficult to improve the purity of bisoprolol fumarate, and the repeated refining process has low yields, poor product stability, making it difficult to achieve large-scale production.

Method used

Bisoprolol free base combined with non-fumaric acid organic acid to form organic acid, and is refined by recrystallization of mixed solvents, and finally reacts with sodium carbonate in dichloromethane-aqueous solution to convert it into high-purity fumaric acid pesoso fumaric acid Lor.

Benefits of technology

The product purity exceeds 99.5% after a single refining, simplifying the process, improving the preparation efficiency, ensuring product stability, and suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118908845A_ABST
    Figure CN118908845A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of bisoprolol fumarate. The preparation method comprises the following steps: salifying bisoprolol and organic acid; refining the salt with an organic solvent; and converting the bisoprolol organic acid salt into the bisoprolol fumarate. According to the method, through conversion and purification of acid radicals, single impurities and total impurities of bisoprolol fumarate are effectively reduced, the purity of the finally obtained bisoprolol fumarate is larger than 99.5%, and the single impurity is smaller than 0.05%. The process is simple and convenient to operate, avoids the defects that bisoprolol fumarate is refined for multiple times and impurities are not easy to control, and is suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pharmaceutical compound preparation, and particularly relates to a method for preparing bisoprolol fumarate. Background Art

[0002] Bisoprolol fumarate is a highly selective long-acting beta-receptor blocker, which is clinically used to treat hypertension, angina pectoris, arrhythmia and other diseases. Its structural formula is shown below:

[0003]

[0004] The synthesis route is: 4-hydroxybenzyl alcohol is used as a raw material and etherified with 2-isopropoxyethanol at a high temperature of 150°C, and then salified with epichlorohydrin, isopropylamine and fumaric acid in four steps to synthesize the target product, as shown in the following formula:

[0005]

[0006] The traditional method requires repeated purification of bisoprolol fumarate to remove impurities to meet the European (EP) Pharmacopoeia standard requirements (product purity greater than 99.0%).

[0007] Publication patent WO2007069266 dissolves bisoprolol free base in an organic solvent, acetone, and adds fumaric acid. After crystallization, crude bisoprolol fumarate is obtained, and then refined bisoprolol fumarate is obtained through multiple refining. However, the purity of the bisoprolol fumarate still needs to be improved.

[0008] The prior art proposes a method for refining bisoprolol free base, which has the effect of reducing the content of impurity A. However, the yield is low when the prior art method is repeated. Moreover, since bisoprolol free base is an oily substance, the product has poor stability and is easy to deteriorate, which will cause inconvenient operation and low yield of the final product, and large-scale production cannot be achieved. Summary of the invention

[0009] The purpose of the present application is to provide a method for preparing high-purity bisoprolol fumarate, wherein the purity of the obtained bisoprolol fumarate is higher than 99.5%. In order to achieve this effect, the present application provides the following technical solutions:

[0010] A method for preparing bisoprolol fumarate comprises the following steps:

[0011] Step 1. salting bisoprolol free base with an organic acid in an organic solvent to obtain bisoprolol organic acid salt; the organic acid is not fumaric acid;

[0012] Step 2. Recrystallizing and refining the bisoprolol organic acid salt in a mixed solvent;

[0013] Step 3. The refined bisoprolol organic acid salt is converted into bisoprolol fumarate.

[0014] Furthermore, in step 1, the organic acid is selected from a mixture of one or more of benzoic acid, malonic acid, and succinic acid; and the organic solvent is one of acetone and isopropanol or a mixture of both.

[0015] The organic solvent is preferably a mixture of acetone and isopropanol in a volume ratio of 1:1.

[0016] The molar ratio of the bisoprolol to the organic acid is in the range of 1:1 to 1:2.5, preferably 1:1 to 1:2.

[0017] Preferably, in step 1, the salt formation temperature is 30°C to 55°C, preferably 45°C to 55°C.

[0018] Furthermore, in step 2, the mixed solvent is a mixture of acetonitrile and ethyl acetate.

[0019] Preferably, in step 2, in the mixed solvent, the volume ratio of acetonitrile to ethyl acetate is 1:2 to 1:5, preferably 1:3 to 1:4.

[0020] Further preferably, in step 2, the volume mass ratio of the total volume of the mixed solvent to the mass of the bisoprolol organic acid salt is 3 to 8 ml / g, preferably 5 to 6 ml / g.

[0021] Preferably, in step 2, the recrystallization dissolution temperature is 30°C to 70°C, preferably 50°C to 65°C.

[0022] Preferably, in step 2, the recrystallization temperature is -10°C to 20°C, preferably 0 to 5°C.

[0023] Preferably, in step 2, the recrystallization time is 1 to 5 hours, preferably 3 to 4 hours.

[0024] Furthermore, in step 3, the method for converting the organic acid salt into bisoprolol fumarate is: neutralizing the organic acid with sodium carbonate or sodium bicarbonate in a dichloromethane-water solution, concentrating under reduced pressure, and then adding acetone and fumaric acid to form a salt to obtain bisoprolol fumarate.

[0025] In the dichloromethane-water solution, the volume ratio of dichloromethane to water is 2:1; the mass ratio of bisoprolol organic acid salt to sodium bicarbonate is 4:1-5.5:1.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] 1. The traditional method needs to purify bisoprolol fumarate repeatedly to remove impurities to meet the European Pharmacopoeia (EP) standard requirements (product purity is greater than 99.0%); the present invention only needs to purify bisoprolol organic acid salt once and then convert it into bisoprolol fumarate. The product purity is greater than 99.5%, and the single impurity is less than 0.05%. The obtained product has high purity, and the processing flow is short, thereby improving the preparation efficiency.

[0028] 2. The present application provides a technical solution for combining bisoprolol with other organic acids other than fumaric acid to obtain a bisoprolol organic acid salt, removing impurities by refining the bisoprolol organic acid salt, and finally preparing purified bisoprolol fumarate; this solution is different from the prior art process of first preparing bisoprolol fumarate and then refining it, and provides a new preparation idea.

[0029] 3. The conditions of this application are mild, and there is no low-temperature or high-temperature reaction in the entire route, and all reactions are within the conventional reaction temperature range. Due to the reasonable temperature range and appropriate acidity and alkali, the obtained product does not show degradation or increase of impurities.

[0030] 4. The whole process of this application does not involve the introduction of strong acid or strong alkali, the amount of wastewater is small, it is environmentally friendly, and meets the needs of large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.

[0032] Figure 1 The chromatogram of the refined bisoprolol fumarate obtained in step 2 of Comparative Example 1;

[0033] Figure 2 The chromatogram of bisoprolol fumarate obtained by multiple purification in step 3 of Comparative Example 1;

[0034] Figure 3 This is the chromatogram of bisoprolol fumarate prepared in Example 1 of the present application;

[0035] Figure 4 This is the chromatogram of bisoprolol fumarate prepared in Example 2 of the present application;

[0036] Figure 5 This is the chromatogram of bisoprolol fumarate prepared in Example 3 of the present application;

[0037] Figure 6 This is the chromatogram of bisoprolol fumarate prepared in Example 4 of the present application;

[0038] Figure 7 This is the chromatogram of bisoprolol fumarate prepared in Example 5 of the present application. DETAILED DESCRIPTION

[0039] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0040] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0041] Detection method: The following detection method is used in both the examples and comparative examples of this case:

[0042] Determined by high performance liquid chromatography. Use octadecylsilane bonded silica gel as filler; 0.05 mol / L diammonium hydrogen phosphate solution as mobile phase A, acetonitrile containing 0.1% phosphoric acid as mobile phase B; gradient elution; column temperature 30°C; flow rate 1.0 ml per minute; detection wavelength 225 nm. The gradient is:

[0043] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0 90 10 20 60 40 40 30 70 60 30 70 61 90 10 75 90 10

[0044] The bisoprolol used in the following comparative examples and the examples of this case were all prepared by the preparation method of WO2007069266.

[0045] Comparative Example 1: WO2007069266

[0046] 1. Repeat example 5 in the patent

[0047] Add 100 ml of acetone and 36 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 40°C, add 6.54 g of fumaric acid. Heat the solution to 56°C and reflux for 30 min. Cool to 2°C and stir to crystallize for 1 h, filter, and wash the filter cake four times with 10 ml of acetone respectively. Dry under vacuum at 50°C for 6 h to obtain 30 g of crude bisoprolol fumarate.

[0048] 2. Repeat example 6 in the patent

[0049] Add 100 ml of acetone and 30 g of crude bisoprolol fumarate to a 250 ml four-necked reaction bottle, stir and heat to 56 °C and reflux for 30 min. Filter while hot, cool the filtrate to 2 °C, stir and crystallize for 1 h, filter, and wash the filter cake four times with 10 ml of acetone respectively. Dry at 50 °C in vacuum for 6 h to obtain 27.1 g of refined bisoprolol fumarate, see the spectrum. Figure 1 . Total yield of two steps: 63.9%. Purity: 98.00%, which is relatively poor.

[0050] 3. In order to solve the problem of poor purity of the product obtained by the method of WO2007069266 patent, multiple refinings are carried out to improve the purity.

[0051] Repeat the second step continuously, and use acetone to co-purify bisoprolol fumarate three times to obtain 19.6g of bisoprolol fumarate triple recrystallization product. The purity is 99.098%, and the spectrum is shown in Figure 2 The total yield is 46.2%. The yield is low.

[0052] Example 1 of this case:

[0053] 1. Preparation of Bisoprolol Organic Acid Salt:

[0054] Add 50 ml of acetone, 50 ml of isopropanol, and 36 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 45°C, add 13.7 g of benzoic acid, keep at 50°C for 30 min, cool to 0°C, stir and crystallize for 2 h, filter to obtain a filter cake, and vacuum dry at 50°C for 6 h to obtain 46.2 g of bisoprolol benzoate.

[0055] 2. Refining of Bisoprolol Benzoate:

[0056] In a 500 ml four-necked reaction bottle, add 46.2 g of bisoprolol benzoate, 58 ml of acetonitrile and 175 ml of ethyl acetate, heat to 50°C and stir to dissolve, cool to 3°C and stir to crystallize for 1 hour, filter to obtain 43.7 g of bisoprolol benzoate. Yield: 94.6%.

[0057] 3. Preparation of Bisoprolol Fumarate:

[0058] In a 500ml four-necked bottle, add 43.7g of refined bisoprolol benzoate, 200ml of dichloromethane, 100ml of water, and 8.4g of sodium bicarbonate, stir for 0.5h, filter, and concentrate the filtrate at 35°C under reduced pressure. Add 150ml of acetone and 11.8g of fumaric acid to the concentrate, heat to 50°C and stir for 30min, cool to 5°C and stir to crystallize for 1h, filter, and vacuum dry at 50°C for 6h to obtain 28.7g of bisoprolol fumarate.

[0059] The total yield of the three steps is 67.7%. The purity of the finished product is 99.506%. Figure 3 .

[0060] Example 2 of this case:

[0061] 1. Preparation of Bisoprolol Organic Acid Salt:

[0062] Add 55 ml of acetone, 55 ml of isopropanol, and 40 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 45°C, add 15.3 g of benzoic acid. Keep at 45°C for 30 min. Cool to 1°C and stir to crystallize for 2 h, filter to obtain a filter cake. Dry under vacuum at 50°C for 6 h to obtain 51.4 g of bisoprolol benzoate.

[0063] 2. Refining of Bisoprolol Benzoate:

[0064] In a 500 ml four-necked reaction bottle, add 51.4 g of bisoprolol benzoate, 65 ml of acetonitrile and 195 ml of ethyl acetate, heat to 30°C and stir to dissolve, cool to 0°C and stir to crystallize for 3 h, filter to obtain 48.8 g of bisoprolol benzoate.

[0065] 3. Preparation of Bisoprolol Fumarate:

[0066] In a 500ml four-necked bottle, add 48.8g of refined bisoprolol benzoate, 250ml of dichloromethane, 130ml of water, and 9.4g of sodium bicarbonate, stir for 0.5h, filter, and concentrate the filtrate at 35°C under reduced pressure. Add 180ml of acetone and 13.2g of fumaric acid to the concentrate, heat to 50°C and stir for 30min, cool to 5°C and stir to crystallize for 1h, filter, and vacuum dry at 50°C for 6h to obtain 32.1g of bisoprolol fumarate.

[0067] The total yield of the three steps is 68.1%. The purity of the finished product is 99.746%. Figure 4 .

[0068] Example 3 of this case:

[0069] 1. Preparation of Bisoprolol Organic Acid Salt:

[0070] Add 50 ml of acetone, 50 ml of isopropanol, and 35 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 55°C, add 13.6 g of benzoic acid. Keep at 55°C for 30 min. Cool to 0°C and stir to crystallize for 2 h, filter to obtain a filter cake. Dry under vacuum at 50°C for 6 h to obtain 46.0 g of bisoprolol benzoate.

[0071] 2. Refining of Bisoprolol Benzoate:

[0072] In a 500 ml four-necked reaction bottle, add 46.0 g of bisoprolol benzoate, 55 ml of acetonitrile and 220 ml of ethyl acetate, heat to 50°C and stir to dissolve, cool to 5°C and stir to crystallize for 4 hours, filter to obtain 43.5 g of bisoprolol benzoate.

[0073] 3. Preparation of Bisoprolol Fumarate:

[0074] In a 500ml four-necked bottle, add 43.5g of refined bisoprolol benzoate, 200ml of dichloromethane, 100ml of water, and 8.5g of sodium bicarbonate, stir for 0.5h, filter, and concentrate the filtrate at 35°C under reduced pressure. Add 150ml of acetone and 12.1g of fumaric acid to the concentrate, heat to 50°C and stir for 30min, cool to 5°C and stir to crystallize for 2h, filter, and vacuum dry at 50°C for 6h to obtain 29.1g of bisoprolol fumarate.

[0075] The total yield of the three steps is 70.6%. The purity of the finished product is 99.640%. Figure 5 .

[0076] Example 4 of this case:

[0077] 1. Preparation of Bisoprolol Organic Acid Salt:

[0078] Add 60 ml of acetone, 60 ml of isopropanol, and 30 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 30°C, add 19.2 g of malonic acid. Keep at 30°C for 2 h. Cool to 0°C and stir to crystallize for 3 h, filter to obtain a filter cake. Dry under vacuum at 50°C for 8 h to obtain 31.3 g of bisoprolol malonate.

[0079] 2. Refining of bisoprolol malonate:

[0080] In a 500 ml four-necked reaction bottle, add 31.3 g of bisoprolol malonate, 42 ml of acetonitrile and 210 ml of ethyl acetate, heat to 70°C and stir to dissolve, cool to -10°C and stir to crystallize for 1 hour, filter to obtain 28.8 g of bisoprolol malonate.

[0081] 3. Preparation of Bisoprolol Fumarate:

[0082] In a 500ml four-necked bottle, add 28.8g of refined bisoprolol malonate, 160ml of dichloromethane, 80ml of water, and 7g of sodium bicarbonate, stir for 0.5h, filter, and concentrate the filtrate at 32°C under reduced pressure. Add 150ml of acetone and 4.5g of fumaric acid to the concentrate, heat to 48°C and stir for 1h, cool to 0°C and stir to crystallize for 2h, filter, and vacuum dry at 50°C for 6h to obtain 24.8g of bisoprolol fumarate.

[0083] The total yield of the three steps is 70.1%. The purity of the finished product is 99.701%. Figure 6 .

[0084] Example 5 of this case:

[0085] 1. Preparation of Bisoprolol Organic Acid Salt:

[0086] Add 45 ml of acetone, 45 ml of isopropanol, and 30 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 45°C, add 22.1 g of succinic acid. Keep at 45°C for 2 hours. Cool to 5°C and stir to crystallize for 3 hours, filter to obtain a filter cake. Dry under vacuum at 45°C for 7 hours to obtain 33.7 g of bisoprolol succinate.

[0087] 2. Refining of Bisoprolol Succinate:

[0088] In a 500 ml four-necked reaction bottle, add 33.7 g of bisoprolol succinate, 34 ml of acetonitrile and 68 ml of ethyl acetate, heat to 65°C and stir to dissolve, cool to 20°C and stir to crystallize for 5 hours, filter to obtain 32.4 g of bisoprolol succinate.

[0089] 3. Preparation of Bisoprolol Fumarate:

[0090] In a 500ml four-necked bottle, add 32.4g of refined bisoprolol succinate, 180ml of dichloromethane, 90ml of water, and 7.2g of sodium bicarbonate, stir for 1h, filter, and concentrate the filtrate at 35°C under reduced pressure. Add 150ml of acetone and 4.7g of fumaric acid to the concentrate, heat to 52°C and stir for 1h, cool to 0°C and stir to crystallize for 2h, filter, and vacuum dry at 50°C for 6h to obtain 24.3g of bisoprolol fumarate.

[0091] The total yield of the three steps is 68.7%. The purity of the finished product is 99.693%. Figure 7 .

[0092] Comparative Example 2: Salt Formation Using Inorganic Acid

[0093] 1. Preparation of Bisoprolol Inorganic Acid Salt (Hydrochloride)

[0094] Add 55 ml of acetone, 55 ml of isopropanol, and 40 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 45°C, add 4.5 g of hydrochloric acid. Keep at 50°C for 30 min under reflux. Cool to 1°C and stir for 2 h to crystallize. No solid precipitates. Subsequent salt purification is not possible.

[0095] 2. Preparation of Bisoprolol Inorganic Acid Salt (Sulfate)

[0096] Add 55 ml of acetone, 55 ml of isopropanol, and 40 g of bisoprolol to a 250 ml four-necked reaction bottle, stir and heat to 45°C, add 12 g of sulfuric acid. Keep at 50°C for 30 min under reflux. Cool to 2°C and stir for 2 h to crystallize. No solid precipitates. Subsequent salt purification is not possible.

[0097] Comparative Example 3: Refining with a single solvent

[0098] 1. Purification of bisoprolol benzoate (using acetonitrile only):

[0099] In a 500ml four-necked reaction bottle, add 46.2g of bisoprolol benzoate and 200ml of acetonitrile, heat to 50°C and stir to dissolve, cool to 3°C and stir to crystallize for 3h, filter to obtain 21.2g of bisoprolol benzoate. Yield: 45.9%, which is lower than the refining yield of 94.6% in the second step of Example 1 of this case.

[0100] 2. Refining of bisoprolol benzoate (using only ethyl acetate):

[0101] In a 500ml four-necked reaction bottle, add 46.2g of bisoprolol benzoate and 200ml of ethyl acetate, heat to 50°C and stir to dissolve, cool to 2°C and stir to crystallize for 5h, filter, and obtain 19.2g of bisoprolol benzoate. Yield: 41.6%, which is lower than the refining yield of 94.6% in the second step of Example 1 of this case.

[0102] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing bisoprolol fumarate, characterized in that: The steps include: Step 1, bisoprolol free base is salified with an organic acid in an organic solvent to obtain bisoprolol organic acid salt; the organic acid is not fumaric acid; Step 2, refining the bisoprolol organic acid salt by recrystallization in a mixed solvent; Step 3, the refined bisoprolol organic acid salt is converted into bisoprolol fumarate.

2. The preparation method according to claim 1, characterized in that: In step 1, the organic acid is selected from a mixture of one or more of benzoic acid, malonic acid, and succinic acid; and the organic solvent is one of acetone and isopropanol or a mixture of the two.

3. The preparation method according to claim 1, characterized in that: In step 1, the molar ratio of bisoprolol to the organic acid added is in the range of 1:1 to 1:2.

5.

4. The preparation method according to claim 1, characterized in that: In step 2, the recrystallization mixed solvent is a mixture of acetonitrile and ethyl acetate.

5. The preparation method according to claim 1, characterized in that: In step 2, the volume ratio of the mixed solvent acetonitrile and ethyl acetate is 1:2 to 1:

5.

6. The preparation method according to claim 1, characterized in that: In step 2, the volume mass ratio of the total volume of the mixed solvent to the mass of the bisoprolol organic acid salt is 3 to 8 ml / g.

7. The preparation method according to claim 1, characterized in that: The salt formation temperature in step 1 is 30°C to 55°C.

8. The preparation method according to claim 1, characterized in that: In step 2, the recrystallization dissolution temperature is 30°C to 70°C; In step 2, the recrystallization temperature is -10°C to 20°C; In step 2, the recrystallization crystallization time is 1 to 5 hours.

9. The preparation method according to claim 1, characterized in that: In step 3, the method for converting the organic acid salt into bisoprolol fumarate is: in a dichloromethane-water solution, the organic acid is neutralized with sodium carbonate, concentrated under reduced pressure, and then acetone and fumaric acid are added to obtain bisoprolol fumarate.

10. The preparation method according to claim 9, characterized in that: In the dichloromethane-water solution, the volume ratio of dichloromethane to water is 2:1; the mass ratio of bisoprolol organic acid salt to sodium bicarbonate is 4:1-5.5:1.